Skip to content

Role Of Homoeopathic Medicine In The Management Of Chronic Urticaria

A Clinical Study To Assess The Usefulness Of Causation In Homoeopathic Prescription In The Management Of Patients Suffering From Chronic Urticaria With Homoeopathic Remedies - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103738
Enrollment
30
Registered
2026-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Patients qualifying inclusion and exclusion criteria will be included in the study. Proper case taking of all enrolled patients will be done in sta

Sponsors

Dr Amit Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients clinically diagnosed with chronic urticaria. 2.Participants of any gender, including male, female, and transgender individuals, will be eligible for the study. 3.Patients belonging to the age group 18 years to 65 years. 4.Literate patients who can read English or Hindi will be included. 5.Illiterate patients will also be enrolled, and investigators will assist them in completing the questionnaires or scales while ensuring adequate privacy. 6.Participants who will provide informed consent, comply with the study protocols, and attend all scheduled follow-up visits.

Exclusion criteria

Exclusion criteria: 1.Patients suffering from severe systemic illnesses or any other life-threatening conditions. 2.Patients with a history of severe anaphylactic shock. 3.Pregnant and lactating women. 4.Patients who refuse to give informed consent and not willing to come for follow ups.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Individualized homoeopathic medicine based on causation in the management of Chronic Urticaria using Urticaria Activity Score over 7 days(UAS7) before and after the treatmentTimepoint: 12 weeks to 24 weeks

Secondary

MeasureTime frame
To evaluate the changes in the quality of life of patients suffering from chronic urticaria using Chronic Urticaria Quality of Life Questionnaire(CU-Q2oL)Timepoint: 12 weeks to 24 weeks

Countries

India

Contacts

Public ContactDr Amit Kumar

State National Homoeopathic Medical College and Hospital

dr.opsingh10@gmail.com7839318990

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026